Economic and equity evaluation of age restrictions on over-the-counter diet pills and muscle-building supplements
- PMID: 39845401
- PMCID: PMC11751689
- DOI: 10.1093/haschl/qxaf002
Economic and equity evaluation of age restrictions on over-the-counter diet pills and muscle-building supplements
Abstract
Over-the-counter diet pills and muscle-building supplements are linked to increased eating disorder diagnoses, especially among youth. With limited regulatory oversight, minors may unknowingly consume harmful substances leading to other adverse effects. Massachusetts has proposed restricting sales to individuals under 18 years. However, concerns about health equity and unintended consequences arise when proposing new policies. We conducted a cost-effectiveness analysis of the proposed age-restriction policy compared to the status quo, focusing on 2 closed cohorts of males and females aged 0-17 years in Massachusetts over a 30-year time horizon. We evaluated the impact from both societal and health systems' perspectives and further assessed equity implications by modeling 3 racial/ethnic subgroups. The policy is projected to prevent 57 034 eating disorder cases and over 46 000 additional adverse medical events (eg, liver injuries). It would yield 51 749 quality-adjusted life years and generate healthcare savings of $14 million and societal savings of $30 million annually. The Latine subpopulation would see the highest per capita health benefits followed by Black and White residents, respectively. Restricting the sale of these supplements to minors offers both health and economic benefits. These findings underscore the policy's effectiveness, fiscal responsibility, and positive equity impacts, providing confidence for policymakers and the public.
Keywords: adolescent health; adverse medical events; cost-effectiveness analysis; diet pills; distributional cost-effectiveness analysis; eating disorders; economic evaluation; health equity; health policy; muscle-building supplements; prevention; public health policy.
© The Author(s) 2025. Published by Oxford University Press on behalf of Project HOPE - The People-To-People Health Foundation, Inc.
Conflict of interest statement
Conflicts of interest: Please see ICMJE form(s) for author conflicts of interest. These have been provided as supplementary materials.
Figures
Similar articles
-
Economic Value of Initial Implementation Activities for Proposed Ban on Sales of Over-The-Counter Diet Pills and Muscle-Building Supplements to Minors.AJPM Focus. 2023 Apr 29;2(3):100103. doi: 10.1016/j.focus.2023.100103. eCollection 2023 Sep. AJPM Focus. 2023. PMID: 37790657 Free PMC article.
-
Cost-Effectiveness of 5 Public Health Approaches to Prevent Eating Disorders.Am J Prev Med. 2022 Dec;63(6):935-943. doi: 10.1016/j.amepre.2022.07.005. Epub 2022 Sep 13. Am J Prev Med. 2022. PMID: 36109308
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
-
Key Informants' Perceptions of Health Equity and Racial Justice Impacts of the 2019 Massachusetts An Act Modernizing Tobacco Control.Nicotine Tob Res. 2024 May 31;26(Supplement_2):S96-S102. doi: 10.1093/ntr/ntad110. Nicotine Tob Res. 2024. PMID: 38817028 Free PMC article.
References
-
- Streatfeild J, Hickson J, Austin SB, et al. . Social and economic cost of eating disorders in the United States: evidence to inform policy action. Int J Eat Disord. 2021;54(5):851–868. - PubMed
-
- Pomeranz JL, Barbosa G, Killian C, Austin SB. The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. J Public Health Manag Pract. 2015;21(5):496. - PubMed
LinkOut - more resources
Full Text Sources